In cancer, the CHK1 pathway becomes particularly significant due to the high levels of replication stress and genomic instability associated with tumor cells. Many cancer cells rely on CHK1 to manage this stress and avoid catastrophic DNA damage. As a result, CHK1 has become a target for cancer therapy, with inhibitors being developed to prevent its function, thereby causing cancer cells to accumulate lethal levels of DNA damage.
